A further and highly significant improvement in the pharmacology of mAbs was achieved with the production of humanized mAbs that were developed by transplanting murine hypervariable segments of the complementary-determining regions (CDRs) into a human Ab structure [ 10 , 11 , 12 ].
← all excerpts
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.
1
—
—